1703. Efficacy of Selected Metabolic Inhibitors for the Prevention and Resensitization of High-Level Daptomycin Resistance in Streptococcus mitis-oralis In Vitro and in an Ex Vivo Simulated Endocarditis Model

BACKGROUND: Rapid development of stable, high-level daptomycin-resistance (DAP-R) is frequent among Streptococcus mitis-oralis strains during exposure to DAP in vitro and in vivo. Metabolomic analyses of in vitro-derived daptomycin-resistant (DAP-R) S. mitis-oralis strains (351D10) revealed substant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kebriaei, Razieh, Rybak, Michael J, Lapitan, Christian K, Somerville, Greg A, Bayer, Arnold S, Mishra, Nagendra N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752928/
http://dx.doi.org/10.1093/ofid/ofac492.1333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752928/
http://dx.doi.org/10.1093/ofid/ofac492.1333

Ejemplares similares